Breast Cancer
A randomized phase III, double-blind, placebo-controlled multicenter trial of everolimus in combination with trastuzumab and paclitaxel, as first line therapy in women with HER2-positive locally advanced or metastatic breast cancer
Trial ID: 08217
Contact: Sharon S Ambro
Phone: (972)841-8345
Learn More about this trial.
go back | new search